Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.

Pubmed ID: 12062037


  • Giasson BI
  • Duda JE
  • Quinn SM
  • Zhang B
  • Trojanowski JQ
  • Lee VM



Publication Data

May 16, 2002

Associated Grants


Mesh Terms

  • Animals
  • Axons
  • Behavior, Animal
  • Brain
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation
  • Humans
  • Inclusion Bodies
  • Male
  • Mice
  • Mice, Transgenic
  • Microscopy, Electron
  • Movement Disorders
  • Nerve Tissue Proteins
  • Neurodegenerative Diseases
  • Neurons
  • Phenotype
  • Recombinant Fusion Proteins
  • Solubility
  • Spinal Cord
  • Synucleins
  • Wallerian Degeneration
  • alpha-Synuclein